Viatris GX
0885.805.780 · rovalta.com · 25/09/2026
ACTIVE
Viatris GX
Financial year 2025 · Closed on 31/12/2025
Net result407,1 k €+2,9 %over 1 year
Equity27,9 M €+1,5 %over 1 year
Overview
Identity
Source · BCE/KBOViatris GX is a Private limited company incorporated in 2006. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Hoeilaart.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0885.805.780
- Incorporation
- 20/12/2006
- Legal form
- Private limited company
- Registered office
- Terhulpsesteenweg 6A
1560 Hoeilaart · FlandreSee on map - Contributed capital
- 24 576 264,30 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Joint committees (2)
- 200
- 218
Signals
ProfitableSolid equityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 19 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | – | – | 0 € | -100% | 12,9 k € | -100.0% | 28,2 M € | ||
| EBITDA | 686,2 k € | +15.1% | 596 k € | -34.5% | 909,7 k € | +126% | 402,4 k € | -52.3% | 844,5 k € |
| Operating result | 665,7 k € | +16.6% | 570,8 k € | -35.0% | 878,6 k € | +138% | 369,8 k € | -82.4% | 2,1 M € |
| Net result | 407,1 k € | +2.9% | 395,4 k € | -30.9% | 571,9 k € | +232% | 172,1 k € | -87.3% | 1,4 M € |
| Balance sheet | |||||||||
| Equity | 27,9 M € | +1.5% | 27,5 M € | +1.5% | 27,1 M € | +2.2% | 26,6 M € | +7.6% | 24,7 M € |
| Total assets | 31,1 M € | -0.6% | 31,3 M € | -0.1% | 31,3 M € | -23.4% | 40,9 M € | -25.9% | 55,2 M € |
| Cash | – | – | – | 1,4 M € | +69.2% | 848,3 k € | |||
| Debts | 3,2 M € | -15.7% | 3,8 M € | -10.3% | 4,2 M € | -70.8% | 14,3 M € | -52.9% | 30,5 M € |
| Other | |||||||||
| Workforce | – | – | – | 0,0 ETP | -100% | 72,8 ETP | |||
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active · 29 ended
Active mandates
Arun NARAYAN
ActiveTomasz BUCZEK
ActiveEnded mandates
Matthew Salzmann
EndedLuis Birbuet
EndedVincent Verschraegen
EndedVincent Verschraegen
EndedOther companies at this address
Terhulpsesteenweg 6A 1560 Hoeilaart| Company | CBE no. |
|---|---|
AKTUAPHARMA● Active | 0463.582.004 |
Upjohn● Active | 0552.558.025 |
Viatris Healthcare● Active | 0403.048.064 |
| 0463.648.419 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/07/2026 | 27/06/2025 | 27/06/2024 | 12/07/2023 | 11/10/2022 | 13/07/2021 |
| General meeting | 18/06/2026 | 19/06/2025 | 20/06/2024 | 28/06/2023 | 07/10/2022 | 17/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 18/06/2026 | 07/07/2026 | Dutch | |
| Full model | 31/12/2024 | 19/06/2025 | 27/06/2025 | Dutch | |
| Full model | 31/12/2023 | 20/06/2024 | 27/06/2024 | Dutch | |
| Full model | 31/12/2022 | 28/06/2023 | 12/07/2023 | Dutch | |
| Full model | 31/12/2021 | 07/10/2022 | 11/10/2022 | Dutch | |
| Full model | 31/12/2020 | 17/06/2021 | 13/07/2021 | Dutch | |
| Full model | 31/12/2019 | 18/06/2020 | 09/07/2020 | Dutch | |
| Full model | 31/12/2018 | 20/06/2019 | 09/07/2019 | Dutch | |
| Full model | 31/12/2017 | 31/08/2018 | 06/09/2018 | Dutch | |
| Full model | 31/12/2016 | 30/08/2017 | 31/08/2017 | Dutch | |
| Full model | 31/12/2015 | 16/06/2016 | 07/07/2016 | Dutch | |
| Full model | 31/12/2014 | 18/06/2015 | 19/06/2015 | Dutch | |
| Full model | 31/12/2013 | 19/06/2014 | 20/06/2014 | Dutch | |
| Full model | 31/12/2012 | 20/06/2013 | 25/06/2013 | Dutch | |
| Full model | 31/12/2011 | 27/04/2012 | 09/05/2012 | Dutch | |
| Full model | 31/12/2010 | 16/09/2011 | 10/10/2011 | Dutch | |
| Full model | 31/12/2009 | 20/07/2010 | 29/07/2010 | Dutch | |
| Full model | 31/12/2008 | 12/03/2009 | 11/05/2009 | Dutch | |
| Full model | 31/12/2007 | 20/03/2008 | 23/06/2008 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 29 ended
Active mandates
Arun NARAYAN
ActiveTomasz BUCZEK
ActiveEnded mandates
Matthew Salzmann
EndedLuis Birbuet
EndedVincent Verschraegen
EndedVincent Verschraegen
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other02/07/2026—
- Mandates10/12/2025ONTSLAGEN - BENOEMINGEN
- Mandates10/07/2025ONTSLAGEN - BENOEMINGEN
- Mandates21/03/2024ONTSLAGEN - BENOEMINGEN
- Mandates11/07/2023ONTSLAGEN - BENOEMINGEN
- Mandates17/01/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
- Mandates17/05/2021ONTSLAGEN - BENOEMINGEN
- Mandates14/07/2020ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025407,1 k €↑
- 26/11/2025nominationArun Narayan — bestuurder
- 25/06/2025nominationTomasz Buczek — bestuurder
- 2024Annual accounts 2024395,4 k €↓
- 01/03/2024nominationMatthew Salzmann — bestuurder
- 2023Annual accounts 2023571,9 k €↑
- 28/06/2023reconductionDeloitte Bedrijfsrevisoren BV — commissaris
- 2022Annual accounts 2022172,1 k €↓
- 2022Name changeViatris GX BV
- 2020Annual accounts 20201,4 M €↓
- 2019Annual accounts 20191,7 M €↑
- 2018Annual accounts 2018-3 M €↑
- 2017Annual accounts 2017-4,2 M €↑
- 2016Annual accounts 2016-16 M €↓
- 2015Annual accounts 2015-8,4 M €↑
- 2014Annual accounts 2014-12,8 M €↓
- 2013Annual accounts 2013-10,8 M €↓
- 2012Annual accounts 2012-5,6 M €↓
- 2009Annual accounts 20093,4 M €↑
- 2008Annual accounts 20082,2 M €
- 2008Name changeMYLAN
- 20/12/2006IncorporationPrivate limited company